ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,816Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 682

$1.48M Total Retail Price of All Prescriptions

Rank: 40 out of 682

841 Patients Receiving at Least One Drug in Part D
87% Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Kentucky
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 841 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 841 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
FUROSEMIDE 978 884 150 1 7
PRAVASTATIN SODIUM 972 860 190 2 13
OMEPRAZOLE 954 862 177 3 5
HYDROCODONE-ACETAMINOPHEN 941 697 140 S3 4 1
LISINOPRIL 898 759 181 5 3
WARFARIN SODIUM 679 652 98 6 15
LEVOTHYROXINE SODIUM 658 618 117 7 2
METFORMIN HCL 555 465 102 8 10
GABAPENTIN 543 407 110 9 9
SIMVASTATIN 510 471 111 10 6
METOPROLOL TARTRATE 477 431 97 11 11
TRAZODONE HCL 430 366 86 12 41
HYDROCHLOROTHIAZIDE 420 336 80 13 12
NAMENDA 417 417 38 14 29
DONEPEZIL HCL 380 375* 57 15 33
POTASSIUM CHLORIDE 372 302 64 16 14
CARVEDILOL 368 326 66 17 24
ALLOPURINOL 356 314 54 18 35
CLONIDINE HCL 331 239 80 19 56
CLOPIDOGREL 322 307 64 20 16
CYMBALTA 311 203 24 21 45
ATORVASTATIN CALCIUM 305 263 62 22 8
METOPROLOL SUCCINATE 281 241 50 23 17
CITALOPRAM HBR 278 245 63 24 20
AMLODIPINE BESYLATE 272 231 57 25 4
LOSARTAN POTASSIUM 268 237 50 26 19
QUETIAPINE FUMARATE 254 249* 31 A 27 71
LORAZEPAM 253 217 56 B 28 34
SPIRONOLACTONE 251 227 49 29 65
POLYETHYLENE GLYCOL 3350 238 221 64 30 48
BUMETANIDE 237 220 49 31 115
SERTRALINE HCL 233 213 26 32 25
BUSPIRONE HCL 226 203 49 33 87
PANTOPRAZOLE SODIUM 225 188 47 34 23
TRIAMTERENE-HCTZ 225 220* 37 34 62
ESCITALOPRAM OXALATE 204 192 29 36 46
GLIPIZIDE 197 177 34 37 61
TAMSULOSIN HCL 197 192* 40 37 37
ALPRAZOLAM 185 129 33 B 39 18
FAMOTIDINE* 176 147 33 40 93
ATENOLOL 175 145 32 41 21
NEXIUM 173 120 33 42 22
GLIPIZIDE ER 173 149 34 42 125
DIGOX 157 152* 28 44 84
RANITIDINE HCL 150 145* 25 45 30
ROPINIROLE HCL 148 135 26 46 73
ZOLPIDEM TARTRATE 142 100 38 47 28
SOTALOL 141 124 24 48 203
NYSTATIN 141 136* 45 48 83
PREDNISONE 139 125 50 50 42
LANTUS 137 89 30 51 69
PAROXETINE HCL 136 122 26 52 58
MELOXICAM 135 106 23 53 27
MIRTAZAPINE 127 127 20 54 51
LOVASTATIN 125 120* 27 55 75
TIZANIDINE HCL 122 83 44 56 78
PROMETHAZINE HCL 120 84 45 R 57 80
DIOVAN 118 105 20 58 50
FLUTICASONE PROPIONATE 118 81 38 58 38
FENTANYL 117 105 12 S2 60 95
LYRICA 117 106 13 60 79
DILTIAZEM 24HR CD 117 112* 17 60 130
CIPROFLOXACIN HCL 114 109* 72 63 67
ABILIFY 109 <11 <11 A 64 140
SULINDAC 108 103* 35 65 302
SYNTHROID 107 86 19 66 52
LEVETIRACETAM 105 100* 17 67 108
SUCRALFATE 102 83 25 68 146
CRESTOR 102 75 13 68 26
TRAMADOL HCL 101 96* 23 70 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 99 88 20 71 39
QUINAPRIL HCL 95 82 15 72 142
AMOXICILLIN 95 83 70 72 110
LANTUS SOLOSTAR 94 74 14 74 92
KLOR-CON M20 94 65 18 74 74
ALBUTEROL SULFATE 93 88* 45 76 177
TERAZOSIN HCL 91 71 20 77 170
ISOSORBIDE MONONITRATE ER 90 90 14 78 40
NOVOLOG 90 74 19 78 126
RISPERIDONE 89 <11 <11 A 80 89
ADVAIR DISKUS 89 73 22 80 63
FLUOXETINE HCL 87 72 14 82 64
IRBESARTAN 87 73 11 82 173
LOSARTAN-HYDROCHLOROTHIAZIDE 85 80* 21 84 53
TOPIRAMATE 82 <11 <11 85 141
LEVOFLOXACIN 81 76* 43 86 59
DILTIAZEM ER 79 54 19 87 171
NORTRIPTYLINE HCL 79 74* 13 87 242
VENLAFAXINE HCL ER 78 73* 13 89 105
CEFDINIR 76 71* 52 90 158
OXYBUTYNIN CHLORIDE ER 74 61 15 91 163
DILTIAZEM 24HR ER 74 74 17 91 129
CLONAZEPAM 72 <11 <11 B 93 36
VERAPAMIL ER 71 66* 20 94 122
GLIMEPIRIDE 70 65* 14 95 44
DICYCLOMINE HCL 69 42 21 96 210
METFORMIN HCL ER 68 57 14 97 70
ALENDRONATE SODIUM 68 <11 <11 97 49
CEPHALEXIN 68 63* 41 97 119
PROAIR HFA 67 50 24 100 43
IBUPROFEN 64 53 20 101 81
FINASTERIDE 64 64 13 101 114
SPIRIVA 63 <11 <11 103 57
LEVEMIR 61 <11 <11 104 155
PROPRANOLOL HCL 61 37 11 104 137
CARBIDOPA-LEVODOPA 61 61 11 104 136
DIVALPROEX SODIUM 61 <11 <11 104 86
OXYCODONE-ACETAMINOPHEN 59 37 14 S2 108 111
MECLIZINE HCL 58 53* 21 109 116
ENALAPRIL MALEATE 55 43 12 110 97
LANSOPRAZOLE 54 36 11 111 99
RAMIPRIL 54 49* 12 111 96
CALCITONIN-SALMON 54 49* 14 111 292
MIDODRINE HCL 53 <11 <11 114 376
HYDROXYZINE HCL 52 <11 <11 R 115 197
NITROSTAT 50 45* 33 116 168
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 45* 39 116 107
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.